CONFERENCE UPDATE: ACC 2023
Understanding the mechanism of benefits of dapagliflozin in HFpEF: An invasive hemodynamic randomized trial
11 May 2023
Related Articles
CONFERENCE UPDATE: ACC 2023
Understanding the mechanism of benefits of dapagliflozin in HFpEF: An invasive hemodynamic randomized trial